Related by context. All words. (Click for frequent words.) 73 adalimumab Humira 70 Golimumab 69 RANK Ligand inhibitor 69 RoACTEMRA 68 active ankylosing spondylitis 68 ACTEMRA TM 68 ORENCIA R 68 Peginterferon alfa 2b 68 Adalimumab 68 acetonide FA 68 CAELYX 68 Noxafil 68 CIMZIA ™ 68 PROMACTA 67 ORENCIA ® 67 Etanercept 67 TNF Tumor Necrosis Factor 67 Meets Primary Endpoint 67 Lambert Eaton Myasthenic 67 glucocorticoid induced osteoporosis 67 ZOLINZA 67 Cimzia ® 67 Romiplostim 67 Tarceva TM 66 acyclovir Lauriad R 66 Cimzia TM 66 briakinumab 66 Granted Orphan Drug 66 bleeding pallor 66 rasagiline tablets 66 Xyrem ® 66 CIMZIA TM certolizumab pegol 66 Traficet EN 66 rilonacept 66 CIMZIA R 66 TEMODAL 66 Trobalt 66 mitoxantrone plus 66 CIMZIA TM 66 Dasatinib 66 cinacalcet 66 BARACLUDE ® 66 novel oral anticoagulant 66 Raptiva R 66 Investigational Compound 65 Eculizumab 65 alfa 2a 65 IMiDs ® compound 65 Rilonacept 65 Cimzia certolizumab pegol 65 MabCampath 65 rotigotine transdermal patch 65 antiplatelet agent 65 PEGylated anti 65 etanercept Enbrel 65 Betaferon R 65 chronic idiopathic thrombocytopenic purpura 65 Zorbtive TM 65 Tolvaptan 65 Mycophenolate Mofetil 65 Pazopanib 65 relapsed MM 65 Syndrome LEMS 65 BARACLUDE R 65 Tracleer R 65 adult chronic ITP 65 aripiprazole Abilify 65 Cimzia ® certolizumab pegol 65 REMICADE ® 65 Pirfenidone 65 Raptiva ® 65 Vfend 65 serotonin norepinephrine reuptake inhibitor 65 Sodium oxybate 65 docetaxel Taxotere ® 65 STELARA TM 65 icatibant 65 Serdolect ® 65 atherothrombotic events 65 Pemetrexed 65 plus methotrexate 64 Gleevec Glivec 64 selective modulator 64 dual endothelin receptor antagonist 64 SPRYCEL ® 64 ® lenalidomide 64 Increlex ® 64 thetreatment 64 Humira adalimumab 64 FDA APPROVES 64 Simulect 64 TO AVOID PREGNANCY WHILE 64 methylnaltrexone bromide 64 oral prodrug 64 Lubiprostone 64 CYP#A# inhibitor 64 oropharyngeal candidiasis 64 Mycamine 64 MAGE A3 ASCI 64 Bosutinib 64 PROCRIT ® 64 vapreotide acetate 64 Evoltra ® 64 HCl capsules 64 tocilizumab 64 AVASTIN 64 Fondaparinux 64 Shows Efficacy 64 Neupro R 64 Celebrex celecoxib 64 Kepivance 64 non splenectomized 64 Dabigatran etexilate 64 Firazyr 64 thalidomide Thalomid 64 severe idiopathic Restless 64 evaluating tivozanib 64 Glatiramer Acetate 64 receptor tyrosine kinase inhibitor 64 INSPIRE Trial Phase III 64 Somatuline Depot 64 idursulfase 64 Eltrombopag 64 Certican 64 Amrubicin 64 Zavesca ® 64 RAPTIVA 63 Actemra tocilizumab 63 PRIALT 63 pregabalin Lyrica 63 Degarelix 63 Prolongs Survival 63 ZACTIMA 63 Prosaptide 63 Sycrest 63 Rivaroxaban 63 Plaque Psoriasis 63 Investigational Treatment 63 alefacept 63 Certolizumab pegol 63 lucinactant 63 rheumatoid arthritis psoriatic arthritis 63 R Saizen R 63 Aliskiren 63 Ziprasidone 63 PEGylated Fab fragment 63 Ambrisentan 63 pediatric Crohn disease 63 Proquin XR 63 Tigecycline 63 Remicade infliximab 63 Hsp# Inhibitor 63 Inhalation Powder 63 divalproex sodium 63 Arranon 63 Posaconazole 63 riociguat 63 Monotherapy 63 Clolar ® 63 TNF alpha inhibitor 63 basiliximab 63 APTIVUS 63 INVEGA ® 63 Certolizumab 63 refractory chronic lymphocytic 63 GW# [003] 63 CONBRIZA 63 chronic angina 63 myelodysplastic myeloproliferative diseases 63 FOR FURTHER INFORMATION ABOUT 63 Ozarelix 63 post herpetic neuralgia PHN 63 ankylosing spondylitis AS 63 mild hepatic impairment 63 Sitagliptin 63 sunitinib malate 63 Increlex R 63 HUMIRA 63 Vidaza azacitidine 63 SUTENT ® 63 metastatic malignant 63 Fluconazole 63 YONDELIS 63 8mg/kg 63 severe gastroparesis 63 certolizumab 63 TORISEL 63 Lamotrigine 63 Orphan Designation 63 Thalidomide Pharmion 63 5 lipoxygenase inhibitor 63 Febuxostat 63 Cancidas 63 Methylnaltrexone 63 Dementia Related Psychosis 63 Diabetic Neuropathy 63 PEGINTRON TM 63 OMNARIS HFA 63 REBETOL combination therapy 63 Cariprazine 63 SPRIX ® 63 biologic DMARD 63 Fibrillex TM 63 Ixempra 63 Adjunctive Therapy 63 REVLIMID R 63 panitumumab Vectibix 63 TORISEL TM 63 eltrombopag 63 Patients Treated With 63 investigational pharmacologically unique 62 Acute Ischemic Stroke 62 oropharyngeal candidiasis OPC 62 Receives Orphan Drug Designation 62 Atypical Hemolytic Uremic Syndrome 62 Investigational Drug 62 Friedreich Ataxia FRDA 62 Eszopiclone 62 R lenalidomide 62 Positive Opinion 62 Renal Impairment 62 Alvesco R 62 baminercept 62 orphan designation 62 GTC recombinant human 62 Tibotec Therapeutics division 62 SYCREST 62 FIRAZYR 62 miconazole Lauriad ® 62 Moxifloxacin 62 Orphan Medicinal Product 62 forodesine 62 Hepatotoxicity 62 novel histone deacetylase 62 intranasal formulation 62 Efficacy Results 62 Valsartan 62 darunavir r 62 certolizumab pegol 62 Mirapexin 62 PRISTIQ 62 histamine dihydrochloride 62 Pfizer Sutent 62 decompensated liver disease 62 Zenvia ™ 62 humanized interleukin 6 62 Receives Positive Opinion 62 Orphan Drug designations 62 Relapsed Multiple Myeloma 62 Natalizumab 62 Completes Patient Enrollment 62 efalizumab 62 ciprofloxacin hydrochloride 62 Sebivo 62 Aflibercept 62 Neulasta R 62 rheumatoid arthritis osteoarthritis ankylosing 62 Darunavir 62 Receives Marketing Authorization 62 pemetrexed Alimta 62 interferon gamma 1b 62 somatostatin analog 62 NDA Submission 62 oral methylnaltrexone 62 sorafenib tablets 62 relapsing remitting MS RRMS 62 IRESSA 62 diabetic neuropathic pain 62 Tesamorelin 62 PRN FDA Approves 62 ACOMPLIA R 62 Mg Uk 62 HCV Protease Inhibitor 62 Nexavar ® 62 ARCALYST ® 62 Infliximab 62 Relapsing Remitting Multiple Sclerosis 62 Vidofludimus 62 ULORIC 62 estramustine 62 Torisel 62 INCB# [003] 62 subcutaneous formulation 62 subcutaneously administered 62 Vitrasert R 62 ARIXTRA R 62 Demonstrates Significant 62 tinidazole 62 Demonstrates Positive 62 relapsing multiple sclerosis 62 Aryplase 62 desvenlafaxine succinate 62 Tocilizumab 62 Juvenile Idiopathic Arthritis 62 ABILIFY R 62 inhaled iloprost 62 pain palliation 62 hypereosinophilic syndrome 62 REMINYL ® 62 Evoltra 62 R sorafenib tablets 62 IMiDs R 62 AVAPRO 62 adenosine injection 62 Castration Resistant Prostate Cancer 62 Gefitinib 62 Q#IR 62 REVLIMID ® 62 ALVESCO R 62 denileukin diftitox 62 Pegloticase 62 Antitumor Activity 62 opioid induced bowel dysfunction 62 Plicera 62 FRAGMIN 62 esophageal candidiasis 62 Epratuzumab 62 Dacogen decitabine 62 mertansine 62 Linagliptin 62 SUSTENNA TM 62 Capesaris 62 Survival Benefit 62 refractory gout 62 NOXAFIL Oral Suspension 62 Improves Outcomes 62 Xeloda ® 62 Zarnestra 62 Tracleer ® bosentan 62 duloxetine hydrochloride 62 investigational humanized monoclonal antibody 61 SCH # 61 Submits NDA 61 Oracea ® 61 Nilotinib 61 SinuNase TM 61 Teriflunomide 61 Ciclesonide 61 Luteinizing Hormone Releasing Hormone 61 Long Term Efficacy 61 alvimopan 61 desvenlafaxine 61 OMP designation 61 lenalidomide Revlimid R 61 Pulmonary Arterial Hypertension 61 anthracycline taxane 61 Silodosin 61 rhIGF-I/rhIGFBP-3 61 ARIXTRA 61 Frova R 61 Avastin bevacizumab 61 Hycamtin ® 61 Belimumab 61 paliperidone ER 61 DPNP 61 adefovir dipivoxil 61 SomatoKine 61 ARCALYST 61 Eraxis 61 Denufosol 61 AERIUS 61 Prospective Randomized 61 salmeterol fluticasone 61 peginterferon alfa 61 Genentech Rituxan 61 Vandetanib 61 DepoDur 61 mu opioid receptor antagonist 61 MACUGEN 61 R bendamustine hydrochloride 61 Fludara ® 61 LUCENTIS 61 recurrent glioblastoma multiforme 61 Troxatyl TM 61 Romidepsin 61 Nivestim 61 CYT# potent vascular disrupting 61 olmesartan medoxomil hydrochlorothiazide 61 Rheumatoid Arthritis Patients 61 FROVA 61 HFA MDI 61 Lenalidomide 61 Valdoxan 61 romiplostim 61 weekly subcutaneous injections 61 Aloxi ® 61 Antitumor 61 Severe Asthma 61 receiving prophylactic anticoagulation 61 ADP receptor antagonist 61 Known hypersensitivity 61 Tasimelteon 61 ARCOXIA 61 UPLYSO 61 ABILIFY ® 61 Sanvar R 61 Ophena TM 61 NOXAFIL 61 administered concomitantly 61 Oropharyngeal Candidiasis 61 Intravitreal 61 ACZ# 61 ELIQUIS 61 either acutely decompensated 61 Initiate Clinical Trial 61 Tiotropium 61 Telithromycin 61 posaconazole 61 opioid induced constipation OIC 61 Phase IIb Trial 61 Alkeran 61 ARIKACE 61 leukotriene receptor antagonists 61 Initiates Enrollment 61 Treated Patients 61 HQK 61 teriflunomide 61 Yondelis ® 61 pegylated interferon alpha 61 atazanavir sulfate 61 Adjuvant Treatment 61 Diabetic Macular Edema 61 Angiox R 61 Rotigotine 61 Helicobacter pylori eradication 61 pseudobulbar affect PBA 61 Phase 2b Clinical Trial 61 dalteparin 61 Seroquel quetiapine fumarate 61 severe hypercholesterolemia 61 Navelbine ® 61 Coadministration 61 Phase III Clinical Trial 61 liposomal formulation 61 aspirin clopidogrel 61 Capsules CII 61 octreotide acetate 61 immune thrombocytopenic purpura ITP 61 erlotinib Tarceva ® 61 Elagolix 61 Chronic Hepatitis C 61 LymphoStat B belimumab 61 GRALISE 61 Targretin capsules 61 HBeAg + 61 Complicated Skin 61 Tezampanel 61 Gemzar ® 61 KRN# 61 Aloxi injection 61 Tasigna nilotinib 61 prucalopride 61 immunomodulatory therapy 61 Esbriet ® 61 Patients Treated 61 Zavesca R 61 Carfilzomib 61 hoFH 61 Fludarabine 61 Forsteo 61 OHR/AVR# 61 Soriatane 61 HuMax EGFr 61 sitaxsentan 61 Refractory Hodgkin Lymphoma 61 FAMPYRA 61 Cutaneous T 61 ILUVIEN ® 61 Cypher Sirolimus 61 PEGylated interferon beta 1a 61 dasatinib Sprycel ® 61 MOVIPREP R 61 Pivotal Phase III 61 Atomoxetine 61 Pharmacokinetics PK 61 melphalan prednisone 61 PEG interferon 61 MabThera rituximab 61 REVLIMID lenalidomide 61 Enzyme Replacement Therapy 61 Angioedema 61 severe hypersensitivity reactions 61 Detrol Detrol LA 61 Ranolazine 61 everolimus tablets 61 oral rivaroxaban 61 Oral Fingolimod 61 BYETTA ® 61 mcg BID 61 Glufosfamide 61 JAK Inhibitor 61 DIFICID ™ 61 Effexor venlafaxine 61 markets Gelclair R 61 Announces Tentative Approval 61 ISTODAX ® 61 Hepatitis C Genotype 61 highly purified pasteurized 61 Wafer polifeprosan 61 C1 Inhibitor 61 liposome injection 61 Aloxi R 61 Teflaro 61 Paliperidone Palmitate 61 secondary hyperparathyroidism 61 Glatiramer acetate 61 multicenter multinational 61 Roflumilast 61 Improved Survival 61 plus prednisone prednisolone 61 Decitabine 61 mcg QD 61 Nebulized 61 volociximab 61 receiving INTRON 61 sitagliptin metformin 61 Kineret R 61 constipation OIC 61 JAK2 Inhibitor 61 ankylosing spondylitis psoriatic arthritis 61 antibody MAb 61 DASISION 61 diabetic gastroparesis 61 EMBEDA ™ 61 KIACTA ™ 61 Pivotal Study 60 injectable formulations 60 RhuDex ® 60 BARACLUDE r 60 Initiates Phase III 60 Abrupt discontinuation 60 Campath ® 60 Triapine 60 sargramostim 60 aztreonam 60 Severe Sepsis 60 BCG refractory carcinoma 60 Single Dose 60 levocetirizine 60 palonosetron 60 FOLFOX6 60 Mipomersen 60 Initiates Phase II 60 oxycodone CR 60 Demonstrate Significant 60 Rheumatoid Arthritis RA 60 PD LID 60 sunitinib Sutent 60 Preotact R 60 chemotherapy induced neutropenia 60 memantine HCl 60 induced macular edema 60 arthritis PsA 60 UCB Cimzia 60 GlaxoSmithKline Requip 60 Aceon 60 Patients Receiving 60 ONTAK 60 SEBIVO 60 orphan medicinal product 60 Carbidopa 60 Maribavir 60 leukopenia pancytopenia thrombocytopenia 60 alfuzosin 60 torsemide ER 60 LEVAQUIN ® 60 balsalazide disodium Capsules 60 azilsartan medoxomil 60 tegaserod 60 relapsed multiple myeloma 60 Milnacipran 60 cinacalcet HCl 60 Daptomycin 60 canakinumab 60 COLAZAL R 60 PKC# 60 tolterodine ER 60 Demonstrates Efficacy 60 Progressive Multifocal Leukoencephalopathy 60 risperidone Risperdal 60 subcutaneous ORENCIA 60 RAPAFLO 60 Restless Legs Syndrome RLS 60 granted orphan medicinal 60 nicardipine 60 Launches Generic Version 60 Angiox 60 Ganciclovir 60 formerly LymphoStat B 60 Melphalan 60 Marketing Authorisation Application 60 investigational monoclonal antibody 60 oral antiviral 60 IV acetaminophen 60 colesevelam HCl 60 PROVIGIL 60 rufinamide 60 H2 antagonists 60 Atrasentan 60 Dyloject TM 60 Neurodex 60 QVAR 60 EVIZON ™ 60 INC# 60 Angiox ® 60 Anti TNF 60 AGILECT R 60 Hormone Refractory Prostate Cancer 60 Nexavar sorafenib 60 Dacogen injection 60 EVIZON TM 60 Plecanatide 60 INFERGEN 60 DexaSite 60 HoFH 60 Inhalation Aerosol 60 IBS C 60 Archexin 60 CCX# B 60 Microplasmin 60 Orphan Status 60 miconazole Lauriad R 60 Pafuramidine 60 rFVIIa 60 heterozygous FH 60 Adjunctive 60 superficial bladder cancer 60 RoActemra 60 non metastatic osteosarcoma 60 SNT MC# 60 Emtriva Viread 60 sNDAs 60 Aclasta 60 anti arrhythmic drug 60 maximally tolerated dose 60 chronic immune thrombocytopenic 60 ONGLYZA ™ 60 FUSILEV enhances 60 INVANZ 60 Demonstrated Significant 60 Civacir 60 plus COPEGUS 60 AMMONUL R sodium phenylacetate 60 Personalized Immunotherapy 60 de novo kidney transplant 60 Chronic Hepatitis B 60 SNT-MC#/idebenone 60 Kristalose ® lactulose 60 Kaletra lopinavir ritonavir 60 Ustekinumab 60 Zingo TM 60 Onrigin 60 KETEK 60 oral vancomycin 60 FEMALES SHOULD BE ADVISED 60 Alpha interferons including 60 IMiDs ® 60 CG# [003] 60 neovascular age 60 Rasagiline 60 Irinotecan 60 EFFEXOR XR 60 inhalation powder 60 post menopausal osteoporosis 60 Marketing Authorization Applications 60 Epirubicin 60 Zavesca r 60 benign prostatic hypertrophy BPH 60 methylnaltrexone 60 Octreolin 60 INTEGRILIN ® 60 invasive candidiasis 60 APTIVUS r 60 Antipsychotic 60 REMICADE infliximab 60 ergot derivatives 60 Vidaza R 60 Aztreonam lysine 60 Clinical Trial Evaluating 60 mild vasodilator 60 Peginterferon 60 Xenazine ® 60 Copegus ribavirin 60 sorafenib Nexavar 60 Argatroban 60 Kuvan R 60 generation purine nucleoside 60 Nimotuzumab 60 FDA Accepts 60 calcineurin inhibitor 60 Egrifta 60 MYLOTARG 60 Receives Orphan Drug 60 Rebif ® 60 D aspartate NMDA receptor 60 IMiDs 60 alpha interferons 60 Saforis 60 beta 1a 60 Achieves Primary Endpoint 60 Keppra ® levetiracetam 60 adalimumab 60 Newly Diagnosed Multiple Myeloma 60 chronic eosinophilic leukemia 60 FIRMAGON R 60 factor TNF receptor 60 Brinavess 60 ANDA Filing 60 Initiates Clinical Trial 60 ritonavir boosted 60 Omalizumab 60 Kit CD# positive 60 Dupuytren Contracture 60 budesonide inhalation suspension 60 Perforomist ™ Inhalation Solution 60 chronic ITP patients 60 TYGACIL 60 investigational oral inhibitor 60 CIPN 60 systemic fungal infections 60 Presents Positive 60 Ischemic 60 Ceflatonin 60 AMMONUL R 60 paroxysmal nocturnal hemoglobinuria PNH 60 administered subcutaneously 60 diarrhea predominant irritable 60 guanfacine extended release 60 Laquinimod 60 Evoltra R 60 pharmacokinetic PK study 60 RAPAFLO R 60 Bazedoxifene 60 Initiates Clinical 60 herpetic keratitis 60 Fabry Disease 60 Actimmune ® 60 Successfully Completes Phase 60 TMC# r 60 Arikace 60 BCR ABL inhibitor 60 Spiegelmer ® 60 severe plaque psoriasis 60 Rituxan rituximab 60 risedronate sodium tablets 60 metaglidasen 60 Omacetaxine 60 Pegasys ® 60 Interferon Beta 60 TNF inhibitor therapy 60 biliary tract cancer 60 Interferon beta 1b 60 liver resection surgeries 60 alemtuzumab treated 60 intensive lipid lowering 60 ezogabine 60 Relapsing Multiple Sclerosis 60 samalizumab 60 HMG CoA reductase inhibitors 60 monoclonal anti 60 Cx# [002] 60 Cethromycin 60 delivers fluocinolone acetonide FA 60 platelet aggregation inhibitor 60 Phase IIb Clinical Trial 60 idiopathic thrombocytopenic purpura ITP 60 XGEVA 60 Tarceva erlotinib 59 biologic therapy 59 AGILECT ® 59 Doxil ® 59 visilizumab 59 Budesonide foam crofelemer 59 Itraconazole 59 Nabi HB Intravenous 59 SJIA 59 tapentadol ER 59 Orphan Drug status 59 pomalidomide 59 Panzem R 59 Metformin GR 59 Hematologic 59 Bifeprunox 59 Androxal TM 59 investigational antiplatelet agent 59 Keppra ® 59 docetaxel Taxotere R 59 EMSAM 59 SPIRIVA ® 59 THALOMID 59 fosbretabulin 59 Tolerability 59 imatinib Gleevec ® 59 Icatibant 59 standard chemotherapy regimen 59 tipifarnib 59 Phase 2b Study 59 Grants Orphan Drug 59 Benazepril 59 Previously Untreated 59 VELCADE melphalan 59 miconazole MBT 59 Tumor Response 59 Amigal TM 59 Mylan Receives Approval 59 Bezielle 59 agalsidase alfa 59 SEROQUEL XR 59 Reminyl galantamine 59 DEB# 59 ALVESCO 59 Bevacizumab 59 PENTASA 59 Medoxomil 59 subependymal giant cell 59 SUPPRELIN R LA 59 potentially hepatotoxic 59 Is Well Tolerated 59 paclitaxel poliglumex 59 bortezomib Velcade 59 abacavir lamivudine 59 INTEGRILIN 59 Alitretinoin 59 pimecrolimus cream 59 AZILECT R 59 Liprotamase 59 sapropterin dihydrochloride 59 Invasive Fungal Infections 59 Serious adverse reactions 59 protease inhibitors PIs 59 TYZEKA 59 Gleevec resistant 59 Clevudine 59 chronic HBV 59 peripherally acting 59 Virologic 59 LymphoStat B TM 59 IL# PE#QQR 59 Orally administered 59 Elesclomol 59 novel VDA molecule 59 Topotecan 59 Peginterferon Alfa 2a 59 Arzerra ofatumumab 59 BENLYSTA ® 59 Filgrastim 59 Multaq dronedarone 59 sublingual tablets 59 ISTODAX 59 Gel repository corticotropin injection 59 valdecoxib 59 Aviptadil 59 goserelin 59 Novel Compound 59 mycophenolate mofetil 59 Etravirine 59 factor TNF 59 Zenpep 59 Fast Track Designation 59 interferon alfa 2b 59 Dapagliflozin 59 Xelox 59 topical NSAID 59 RAPAMUNE 59 BCG refractory 59 Orally Active 59 Pyridorin 59 Recommends Approval 59 Fast Track designations 59 TELINTRA 59 ALN HPN 59 inhaled treprostinil 59 targeted antifolate 59 Actemra 59 Previously Treated 59 Potent Antiviral Activity 59 Telbivudine 59 PASI scores 59 Safinamide 59 telaprevir VX 59 olanzapine Zyprexa 59 nephrotoxicity 59 XIAFLEX ® 59 Mepact 59 Somatuline R Autogel R 59 Firdapse ™ amifampridine phosphate 59 Mimpara 59 myopathy rhabdomyolysis 59 cetuximab Erbitux ® 59 nasal calcitonin product 59 BROVANA 59 Nasacort AQ 59 Azilect ® 59 Fidaxomicin 59 paroxetine sertraline 59 olanzapine LAI 59 GTC recombinant form 59 #mg Tablets [002] 59 urocortin 2 59 Brilique 59 Pruvel 59 arsenic trioxide injection 59 TroVax ® 59 moderate hepatic impairment 59 R rilonacept Injection 59 VISICOL R 59 FASLODEX 59 gastrointestinal disorders characterized 59 PRT# 59 Gattex 59 PROVENGE ® 59 MGd 59 sodium benzoate prescription 59 Capecitabine 59 intermittent dosing 59 Abatacept 59 Drug Eluting Stent System 59 PRADAXA 59 ibandronate 59 PREZISTA r 59 Significantly Improved 59 purpura ITP 59 ribavirin RBV 59 multiple myeloma MM 59 draining enterocutaneous 59 Sprycel dasatinib 59 Virulizin ® 59 Parathyroid Hormone 59 Dalbavancin 59 Orphan Drug Status 59 Lacosamide 59 placebo dexamethasone 59 erythropoietic 59 VIVITROL ® 59 anthracyclines taxanes 59 Tasigna prolongs 59 coadministration 59 HCD# [002] 59 Idiopathic Pulmonary Fibrosis 59 doxepin HCl 59 DOXIL 59 injectable formulation 59 ONCASPAR 59 severe renal impairment 59 R abatacept 59 Alemtuzumab 59 Hedgehog Pathway Inhibitor 59 beclomethasone dipropionate 59 Toxicities 59 OMAPRO ™ 59 antiarrhythmic drug 59 FDA Approvals 59 sitaxsentan sodium 59 palifermin 59 itraconazole Sporanox 59 mg kg BID 59 Losartan 59 vinorelbine tartrate 59 Vicinium TM 59 Duloxetine 59 Systemic Sclerosis 59 lacosamide 59 TM Drug Eluting 59 Files IND 59 Naive Patients 59 CARBATROL 59 HCV Genotype 59 Keppra ® XR 59 ALN TTR 59 Emselex 59 buccal tablets 59 schizophrenia CIAS 59 pegaptanib 59 tipranavir 59 NEUPOGEN 59 Fast Track Status 59 Advanced Melanoma 59 equine osteoarthritis 59 Gastrointestinal GI 59 AVELOX 59 flutamide 59 amrubicin 59 Vimpat R 59 Well Tolerated 59 HER2 Positive Breast Cancer 59 Presents Preclinical 59 Ecallantide 59 REBETOL combination 59 Pediatric Patients 59 aromatase inhibitor AI 59 Significantly Reduces 59 cisplatin gemcitabine 59 KAPIDEX 59 Entereg R 59 Octreotide 59 indolent NHL 59 Phase III Trial 59 POSIDUR TM 59 Enzastaurin